MedPath

Aztreonam

Generic Name
Aztreonam
Brand Names
Azactam, Cayston
Drug Type
Small Molecule
Chemical Formula
C13H17N5O8S2
CAS Number
78110-38-0
Unique Ingredient Identifier
G2B4VE5GH8

Overview

A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.

Background

A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.

Indication

For the treatment of the following infections caused by susceptible gram-negative microorganisms: urinary tract infections, lower respiratory tract infections, septicemia, skin and skin-structure infections, intra-abdominal infections, and gynecologic infections.

Associated Conditions

  • Bone and Joint Infections
  • Cystic Fibrosis (CF)
  • Febrile Neutropenia
  • Gynecological Infection
  • Intraabdominal Infections
  • Lower Respiratory Tract Infection (LRTI)
  • Osteomyelitis
  • Septic Arthritis
  • Septicemia
  • Skin Infections
  • Urinary Tract Infection
  • Uncomplicated Gonorrhea

FDA Approved Products

Aztreonam
Manufacturer:Fresenius Kabi USA, LLC
Route:INTRAMUSCULAR, INTRAVENOUS
Strength:2 g in 1 1
Approved: 2022/05/06
NDC:63323-402
Aztreonam
Manufacturer:Fresenius Kabi USA, LLC
Route:INTRAVENOUS, INTRAMUSCULAR
Strength:1 g in 1 1
Approved: 2022/05/06
NDC:63323-401
Aztreonam
Manufacturer:Fresenius Kabi USA, LLC
Route:INTRAVENOUS, INTRAMUSCULAR
Strength:1 g in 1 1
Approved: 2021/07/01
NDC:63323-401
Aztreonam
Manufacturer:Fresenius Kabi USA, LLC
Route:INTRAMUSCULAR, INTRAVENOUS
Strength:2 g in 1 1
Approved: 2021/05/18
NDC:63323-402
Aztreonam
Manufacturer:Hospira, Inc.
Route:INTRAVENOUS, INTRAMUSCULAR
Strength:1 g in 1 1
Approved: 2024/01/09
NDC:0409-0829

Singapore Approved Products

AZACTAM FOR INJECTION 1 g/vial
Manufacturer:CATALENT ANAGNI S.R.L.
Form:INJECTION, POWDER, FOR SOLUTION
Strength:1 g/vial
Online:Yes
Approved: 1988/04/29
Approval:SIN00556P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath